The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
Experts say patients should adjust dosage, try prescribed and over-the-counter drugs to help with symptom management and ...
The prevalence of substance use disorders, such as opioid and alcohol use disorders, has created a significant public health ...
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...